Stock Screener App

Frei -

Installieren

33.87

2.20% -0.7255

Ultragenyx Pharmaceutical Inc (RARE)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt RARE? Forum Prognose Aktiensplit

Finanzdaten der Ultragenyx Pharmaceutical Inc-Aktie (RARE)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-09-30	2024-06-30	2024-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	19.53% 166.50	139.29	139.49	147.03	108.83
Operating Expenses	2.78% 274.38	282.23	271.48	263.39	274.18
Benefits Costs and Expenses	2.96% 280.50	289.06	272.71	277.77	279.06
Costs And Expenses	2.96% 280.50	289.06	272.71	277.77	279.06
Operating Income/Loss	24.52% -107.89	-142.94	-131.99	-116.36	-165.35
Income/Loss From Continuing Operations Before Tax	23.88% -114.00	-149.77	-133.21	-130.74	-170.23
Income Tax Expense/Benefit	27.71% 0.947	1.31	0.303	0.858	0.455
Income/Loss From Continuing Operations After Tax	23.91% -114.95	-151.08	-133.52	-131.60	-170.68
Net Income/Loss	23.91% -114.95	-151.08	-133.52	-131.60	-170.68
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	2.26% 98.46	96.29	95.49	86.58	84.29
Diluted Average Shares	2.26% 98.46	96.29	95.49	86.58	84.29
Basic Earnings Per Share	25.48% -1.17	-1.57	-1.40	-1.52	-2.03
Diluted Earnings Per Share	25.48% -1.17	-1.57	-1.40	-1.52	-2.03
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$37.23

0.68%

INCY

$92.90

0.29%

GMAB

$28.92

0.96%

BNTX

$104.39

0.46%

ONC

$312.02

0.74%

INSM

$182.66

3.82%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters